Tackling COVID-19
As we stay apart, pharmaceutical companies are coming together to fight against COVID-19
LEARN MOREIntellectual Property
Europe’s framework of incentives and rewards for discovering and developing new treatments deliver access to today’s medicines and investment into tomorrow’s cures for patients who need them.
LEARN MORE
Help us make rare disease even rarer
Only 8 OMP medicines existed in 2000, before the EU Regulation came in to force, compared to 184 today.
LEARN MORE
Relationships and Code
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals
LEARN MORE
Latest Updates
VIEW ALL-
Blog articles 18.01.21
A lawyers’ ambition for 2021
Now is the time to look back at lessons learned, to think through how we can foster the kind of innovation environment in Europe that can not only solve...
Read Article -
Statements & press releases 14.01.21
EFPIA response to Inception Impact Assessment on Orphan and Paediatric Regulations
EFPIA members are committed to ensuring that unmet needs are addressed and that available treatments reach all European patients
Read Article -
Blog articles 14.01.21
Podcast: How is the pharmaceutical industry contributing to the fight against COVID-19?
Welcome to 19 Conversations
Read Article -
External Events 04.03.21
Value Based Healthcare Conference – Tallinn 2021
The conference aims at raising awareness and knowledge among the healthcare community on the value of patient-centered healthcare.
View Event -
External Events 15.03.21
DIA Europe 2021
Dedicated to Advancing Healthcare Priorities
View Event -
External Events 15.04.21
Innovation for Health
On 15-16 April 2021, the 8th edition of Innovation for Health takes place as a hybrid edition.
View Event
Featured Articles
